Transcutaneous vagus nerve stimulation (tVNS) devices have gained popularity as a way to "hack" the nervous system and improve heart rate variability. The premise is simple: stimulate the vagus nerve through the ear, increase parasympathetic activity, boost HRV.
There's just one problem: a meta-analysis found it doesn't work for most people.
The Meta-Analysis Says No
A Bayesian meta-analysis of 16 single-blind studies examined whether tVNS actually affects vagally-mediated HRV compared to sham stimulation[1].
The result: Strong evidence for the null hypothesis (g = 0.014, meaning essentially zero effect). The researchers concluded there is "no support for the hypothesis that vmHRV is a robust biomarker for acute taVNS."
In practical terms: in the average healthy person, stimulating the ear with electrical pulses doesn't measurably change HRV compared to fake stimulation.
This is a significant finding. It suggests that if you're buying a tVNS device hoping to see your HRV numbers climb, you may be disappointed.
But Some Individual Studies Show Effects
Here's where it gets interesting. Some individual studies DO show significant HRV improvements with tVNS[2][3].
A study of 28 healthy young adults found 10 minutes of active tVNS (at the cymba conchae of the ear) significantly increased[3]:
- RMSSD (p = 0.01)
- SDNN (p = 0.008)
- High-frequency power (p = 0.007)
Another study of 14 healthy college students found tVNS significantly increased HF power (p = 0.001), RMSSD (p = 0.026), and pRR50 (p = 0.027), with effects persisting into the recovery period[2].
So what explains the discrepancy?
The Baseline HRV Predictor
A 2025 study of 110 participants (59 with major depression, 51 controls) revealed the key insight[4].
People with LOW baseline HRV showed improved cardiac vagal reactivity with tVNS. Their nervous systems responded positively to the stimulation.
People with HIGH baseline HRV showed the opposite effect. tVNS actually DECREASED their RMSSD (p < 0.001) and increased their heart rate and inflammatory markers.
The researchers concluded: "Baseline RMSSD matters, at least for the biological outcomes of taVNS. A compromised cardiac parasympathetic activity can be improved by acute taVNS."
This explains the meta-analysis finding: when you average across people with high and low baseline HRV, the effects cancel out.
The Stress Test Problem
Another study tested whether tVNS could protect against stress-induced HRV drops[5].
During the stimulation phase, tVNS did increase RMSSD compared to sham (effect size 0.10). But when participants faced actual mental stress (a socially-evaluated math task), there was "no difference" between groups.
The stress overwhelmed the stimulation effect. This suggests tVNS may not provide meaningful protection during real-world stressors in healthy individuals.
Who Might Actually Benefit
Based on the research, tVNS appears most likely to help if you:
- Have low baseline HRV - The 2025 study showed clear benefits for this group
- Are younger - Age was a moderator; effects were stronger at age 20 than at ages 40-60
- Have a condition associated with autonomic dysfunction - Depression, PTSD, and other conditions with reduced vagal tone may respond better
If you're a healthy person with normal HRV, the evidence suggests tVNS probably won't meaningfully improve your numbers.
Stimulation Parameters That Seem to Work
For those who might benefit, the research suggests:
- Location: Cymba conchae (the inner ear fold) appears more effective than the tragus or helix
- Frequency: 20-25 Hz
- Pulse width: 100-250 microseconds
- Duration: 10-30 minutes
- Intensity: Around 1-2 mA (comfortable, noticeable tingling)
The sham condition (stimulating the earlobe, which has no vagal innervation) serves as a good control in studies but won't do anything in real use.
The Bottom Line
tVNS is not a universal HRV booster. The meta-analysis found no average effect, and stress tests show limited protective capacity.
However, if you have compromised parasympathetic function (low baseline HRV), the research suggests tVNS may genuinely help restore vagal tone. The key is knowing your baseline: if your HRV is already healthy, you probably don't need electrical stimulation.
For most people seeking to improve HRV, the research-backed fundamentals (exercise, sleep, stress management, resonance breathing) remain more reliable than device-based interventions.
Sources
1. Wolf V et al. (2021). Does transcutaneous auricular vagus nerve stimulation affect vagally mediated heart rate variability? A living and interactive Bayesian meta-analysis. Psychophysiology. accessibility.link.new-tab (16 studies, meta-analysis)
2. Geng D et al. (2022). The effect of transcutaneous auricular vagus nerve stimulation on HRV in healthy young people. PLoS ONE. accessibility.link.new-tab (n=14/20, two studies)
3. Peng L et al. (2022). Ear your heart: transcutaneous auricular vagus nerve stimulation on heart rate variability in healthy young participants. PeerJ. accessibility.link.new-tab (n=28, crossover RCT)